false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Envisioning Future Therapies for T1D: Where Biolog ...
Envisioning Future Therapies for T1D: Where Biolog ...
Envisioning Future Therapies for T1D: Where Biology Meets Technology
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the first video, Dr. Carol Weisham, President of the Endocrine Society, discusses the impact of the pandemic on endocrinology and the society's efforts to adapt to virtual meetings. She announces the launch of the hybrid meeting Indo 2022 and mentions other online events like Clinical Endocrine Update and Endocrine Board Review. Dr. Weisham highlights the development of special interest groups, the Endo Cares outreach program, and leadership training for underrepresented communities. She discusses digital learning opportunities and the society's advocacy efforts. Dr. Stephen Hammes introduces the features of the ENDO 2022 event, focusing on advancements in insulin, continuous glucose monitoring, closed-loop insulin delivery systems, and the use of artificial intelligence in diabetes care. He encourages attendees to explore the ENDO Expo.<br /><br />In the second video, a study is summarized where patients were divided into groups receiving advice from either an advisor or a physician, showing no significant difference in outcomes. The video also explores the benefits of clinical decision support systems, including reducing variability in care and integrating with electronic medical records. The importance of collaboration and support for healthcare providers and people with diabetes is emphasized. The second part highlights Dr. Matthias Heberk's research on modifying stem cell-derived beta cell function, discussing the differentiation process and potential applications. The video concludes with acknowledgments to the research team and funding organizations.<br /><br />No specific credits are mentioned in either video.
Keywords
Dr. Carol Weisham
Endocrine Society
virtual meetings
hybrid meeting Indo 2022
clinical decision support systems
insulin advancements
continuous glucose monitoring
closed-loop insulin delivery systems
artificial intelligence in diabetes care
ENDO Expo
collaboration
support for healthcare providers
stem cell-derived beta cell function
potential applications
×